Literature DB >> 16498196

Propofol for sedation in neuro-intensive care.

Michael P Hutchens1, Stavros Memtsoudis, Nicholas Sadovnikoff.   

Abstract

Interventions in the intensive care unit often require that the patient be sedated. Propofol is a widely used, potent sedative agent that is popular in critical care and operating room settings. In addition to its sedative qualities, propofol has neurovascular, neuroprotective, and electroencephalographical effects that are salutory in the patient in neurocritical care. However, the 15-year experience with this agent has not been entirely unbesmirched by controversy: propofol also has important adverse effects that must be carefully considered. This article discusses and reviews the pharmacology of propofol, with specific emphasis on its use as a sedative in the neuro-intensive care unit. A detailed explanation of central nervous system and cardiovascular mechanisms is presented. Additionally, the article reviews the literature specifically pertaining to neurocritical care use of propofol.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16498196     DOI: 10.1385/NCC:4:1:054

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  110 in total

1.  Sedation, analgesia, and neuromuscular blockade of the critically ill adult: revised clinical practice guidelines for 2002.

Authors:  Stanley A Nasraway; Judith Jacobi; Michael J Murray; Philip D Lumb
Journal:  Crit Care Med       Date:  2002-01       Impact factor: 7.598

2.  The role of human lungs in the biotransformation of propofol.

Authors:  A L Dawidowicz; E Fornal; M Mardarowicz; A Fijalkowska
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

3.  Effects of low-dose propofol administration on central respiratory drive, gas exchanges and respiratory pattern.

Authors:  G Rosa; G Conti; P Orsi; F D'Alessandro; I La Rosa; G Di Giugno; A Gasparetto
Journal:  Acta Anaesthesiol Scand       Date:  1992-02       Impact factor: 2.105

4.  [Generalised clonic tonic seizures triggered by anaesthesia with propofol and sevoflurane].

Authors:  A Serrano-Pozo; M M López-Muñoz; E Franco-Macías; F Boza-García; P Chaparro-Hernández
Journal:  Rev Neurol       Date:  2004 Oct 1-15       Impact factor: 0.870

5.  [Asystole during anesthesia with propofol].

Authors:  M Bricchi; M Gemma
Journal:  Ann Fr Anesth Reanim       Date:  1991

6.  Proprofol and the electroencephalogram.

Authors:  B P Hodkinson; R W Frith; E W Mee
Journal:  Lancet       Date:  1987-12-26       Impact factor: 79.321

7.  Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison.

Authors:  A A Weinbroum; P Halpern; V Rudick; P Sorkine; M Freedman; E Geller
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

8.  Propofol impairment of mitochondrial respiration in isolated perfused guinea pig hearts determined by reflectance spectroscopy.

Authors:  K A Schenkman; S Yan
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

9.  Differential changes of autonomic nervous system function with age in man.

Authors:  M A Pfeifer; C R Weinberg; D Cook; J D Best; A Reenan; J B Halter
Journal:  Am J Med       Date:  1983-08       Impact factor: 4.965

10.  Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients.

Authors:  G Conti; D Dell'Utri; V Vilardi; R A De Blasi; P Pelaia; M Antonelli; M Bufi; G Rosa; A Gasparetto
Journal:  Acta Anaesthesiol Scand       Date:  1993-01       Impact factor: 2.105

View more
  9 in total

1.  Vasopressors and propofol infusion syndrome in severe head trauma.

Authors:  Heidi Smith; Grant Sinson; Panayiotis Varelas
Journal:  Neurocrit Care       Date:  2008-12-03       Impact factor: 3.210

2.  Predictors of severe hypotension in neurocritical care patients sedated with propofol.

Authors:  G Morgan Jones; Bruce A Doepker; Michael J Erdman; Lauren A Kimmons; Lucas Elijovich
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

Review 3.  Muscle power during intravenous sedation.

Authors:  Nobuyuki Matsuura
Journal:  Jpn Dent Sci Rev       Date:  2017-03-09

4.  Propofol protects against blood-spinal cord barrier disruption induced by ischemia/reperfusion injury.

Authors:  Li-Jie Xie; Jin-Xiu Huang; Jian Yang; Fen Yuan; Shuang-Shuang Zhang; Qi-Jing Yu; Ji Hu
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

Review 5.  Escalate and De-Escalate Therapies for Intracranial Pressure Control in Traumatic Brain Injury.

Authors:  Denise Battaglini; Pasquale Anania; Patricia R M Rocco; Iole Brunetti; Alessandro Prior; Gianluigi Zona; Paolo Pelosi; Pietro Fiaschi
Journal:  Front Neurol       Date:  2020-11-24       Impact factor: 4.003

6.  Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.

Authors:  Russel J Roberts; Jeffrey F Barletta; Jeffrey J Fong; Greg Schumaker; Philip J Kuper; Stella Papadopoulos; Dinesh Yogaratnam; Elise Kendall; Renee Xamplas; Anthony T Gerlach; Paul M Szumita; Kevin E Anger; Paul A Arpino; Stacey A Voils; Philip Grgurich; Robin Ruthazer; John W Devlin
Journal:  Crit Care       Date:  2009-10-29       Impact factor: 9.097

7.  Continuous online microdialysis using microfluidic sensors: dynamic neurometabolic changes during spreading depolarization.

Authors:  Michelle L Rogers; Delphine Feuerstein; Chi Leng Leong; Masatoshi Takagaki; Xize Niu; Rudolf Graf; Martyn G Boutelle
Journal:  ACS Chem Neurosci       Date:  2013-05-01       Impact factor: 4.418

Review 8.  Optimizing sedation in patients with acute brain injury.

Authors:  Mauro Oddo; Ilaria Alice Crippa; Sangeeta Mehta; David Menon; Jean-Francois Payen; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Crit Care       Date:  2016-05-05       Impact factor: 9.097

9.  Propofol Decreases Endoplasmic Reticulum Stress-Mediated Apoptosis in Retinal Pigment Epithelial Cells.

Authors:  Xuezhi Zhou; Yantao Wei; Suo Qiu; Yue Xu; Ting Zhang; Shaochong Zhang
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.